Metabolic Disorders Terminated Phase 1 Trials for Rivogenlecleucel (DB19107)

Back to Metabolic Disorders

Also known as: Metabolic Disorder / Metabolic disorder, unspecified / Metabolic disorder NOS / Generalized metabolic disorder (disorder) / Unspecified disorder of metabolism / Metabolic disease (disorder) / Metabolic Diseases

Indication	Status	Phase
DBCOND0035995 (Metabolic Disorders)	Terminated	1

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT02231710	Safety Study of Gene Modified Donor T Cell Infusion After Stem Cell Transplant for Non-Malignant Diseases	Treatment	Rimiducid (DB04974) Rivogenlecleucel (DB19107)